Literature DB >> 31567008

Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates.

Elias J Dayoub1,2, Joseph S Ross3,4,5, Nilay D Shah6, Sanket S Dhruva7,8.   

Abstract

Keywords:  Medicare Part C; Medicare Part D; anticoagulants; atrial fibrillation; venous thrombembolism

Year:  2019        PMID： 31567008     DOI： 10.1161/CIRCULATIONAHA.119.040580

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019.

Authors:  Aaron Troy; Timothy S Anderson
Journal:  JAMA Health Forum       Date:  2021-07-23

2.  Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation.

Authors:  Ankur Srivastava; Eric Sun; Aliasakar Hasani; John D Fisher; Kevin J Ferrick; Andrew K Krumerman
Journal:  J Gen Intern Med       Date:  2020-09-15       Impact factor: 6.473

3.  Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.

Authors:  Kevin M Wheelock; Joseph S Ross; Karthik Murugiah; Zhenqiu Lin; Harlan M Krumholz; Rohan Khera
Journal:  JAMA Netw Open       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.